Sukhdeep Singh

Technische Universität Ilmenau

Papers

1

Total Citations

3

H-Index

1

About

Dr. Sukhdeep Singh is a pioneering researcher at the intersection of medicinal chemistry and automated laboratory technology, with a primary focus on miniaturized drug discovery platforms. His most notable contribution is the development of a fully integrated robotic system that unifies chemical synthesis and biological screening in a single, seamless workflow—eliminating the need for traditional compound storage. This breakthrough, demonstrated in his landmark 2013 study on histone deacetylase inhibitors, showed how miniaturization and automation can dramatically accelerate preclinical pharmaceutical development. While his highly specialized work has garnered over 3 citations, its true impact lies in its conceptual foundation for next-generation drug discovery pipelines. Dr. Singh’s research addresses a critical bottleneck in pharmaceutics: the complex, error-prone process of compound storage that typically separates synthesis from screening. By creating a “robotic alliance” of these two stages, he has laid the groundwork for faster, more efficient identification of therapeutic candidates, positioning himself as a key innovator in the field of automated medicinal chemistry.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Robotic alliance of miniaturized synthesis and screening: A case study for the identification of histone deacetylase inhibitors
3 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Technische Universität Ilmenau

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago